E-LIB Suche - Ergebnisse für: Shi, Nianmin

1

Neutralizing antibody activity, safety and immunogenicity o..:

Li, Li ; Li, Yufeng ; Bai, Yunhua...
Vaccine. 40 (2022) 42 - p. 6153-6162 , 2022

Link: https://doi.org/10.1016/..

2

Safety and immunogenicity of a quadrivalent, inactivated, s..:

Huang, Xiaoyuan ; Fan, Ting ; Li, Li...
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

3

Safety and Viral Shedding of Live Attenuated Influenza Vacc..:

Li, Li ; Shi, Nianmin ; Xu, Na...
Vaccines. 10 (2022) 11 - p. 1796 , 2022

Link: https://doi.org/10.3390/..

4

Population Pharmacodynamic Analyses of Human Anti-Rabies Vi..:

Zhang, Junnan ; Shi, Nianmin ; Li, Guohua...
Vaccines. 10 (2022) 8 - p. 1218 , 2022

Link: https://doi.org/10.3390/..

5

Safety of two doses of an inactivated hepatitis a vaccine g..:

Shi, Nianmin ; Rasuli, Anvar ; Thollot, Yaël
Human Vaccines & Immunotherapeutics. 15 (2018) 3 - p. 748-754 , 2018

Link: https://doi.org/10.1080/..

6

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Entero..:

Wei, Mingwei ; Meng, Fanyue ; Wang, Shiyuan...
The Journal of Infectious Diseases. 215 (2017) 1 - p. 56-63 , 2017

Link: http://www.jstor.org/sta..

7

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Entero..:

Wei, Mingwei ; Meng, Fanyue ; Wang, Shiyuan...
Journal of Infectious Diseases. 215 (2016) 1 - p. 56-63 , 2016

Link: https://doi.org/10.1093/..

8

Optimal vaccination strategies for 2009 pandemic H1N1 and s..:

Wu, Jiang ; Zhong, Xiang ; Li, Chris Ka-fai...
Vaccine. 29 (2011) 5 - p. 1009-1016 , 2011

Link: https://doi.org/10.1016/..

9

Safety and immunogenicity of a quadrivalent, inactivated, s..:

Huang, Xiaoyuan ; Fan, Ting ; Li, Li...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621009/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Safety of two doses of an inactivated hepatitis a vaccine g..:

Shi, Nianmin ; Rasuli, Anvar ; Thollot, Yaël
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605741/. , 2018

Link: http://www.ncbi.nlm.nih...

11

Immunogenicity and safety of purified vero cell rabies vacc..:

Wang, Jing ; Luo, FengJi ; Feng, ZiJian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287299/. , 2017

Link: http://www.ncbi.nlm.nih...

12

Analysis of risk factors for persistent infection of asympt..:

Shi, Nianmin ; Lu, Qiang ; Zhang, Jiao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524175/. , 2017

Link: http://www.ncbi.nlm.nih...

13

Immunogenicity, safety and antibody persistence of a purifi..:

Shi, Nianmin ; Zhang, Yibin ; Zheng, Huizhen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489304/. , 2017

Link: http://www.ncbi.nlm.nih...

14

Immunological persistence of a seasonal influenza vaccine i..:

Bai, Yunhua ; Shi, Nianmin ; Lu, Qiang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514239/. , 2015

Link: http://www.ncbi.nlm.nih...

15

A randomized, controlled, blinded study of the safety, immu..:

Li, Shuming ; Li, Li ; Ai, Xing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...